223 related articles for article (PubMed ID: 20668437)
1. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder.
López-Solà M; Pujol J; Hernández-Ribas R; Harrison BJ; Contreras-Rodríguez O; Soriano-Mas C; Deus J; Ortiz H; Menchón JM; Vallejo J; Cardoner N
Neuropsychopharmacology; 2010 Oct; 35(11):2305-17. PubMed ID: 20668437
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
3. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms.
McIntyre RS; Konarski JZ
Expert Opin Pharmacother; 2005 May; 6(5):707-13. PubMed ID: 15934897
[TBL] [Abstract][Full Text] [Related]
5. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
8. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
10. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
Perahia DG; Quail D; Desaiah D; Montejo AL; Schatzberg AF
J Psychiatr Res; 2009 Feb; 43(5):512-8. PubMed ID: 18707693
[TBL] [Abstract][Full Text] [Related]
11. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain.
Strigo IA; Simmons AN; Matthews SC; Craig AD; Paulus MP
Arch Gen Psychiatry; 2008 Nov; 65(11):1275-84. PubMed ID: 18981339
[TBL] [Abstract][Full Text] [Related]
12. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.
Romera I; Pérez V; Menchón JM; Schacht A; Papen R; Neuhauser D; Abbar M; Picard H; Gilaberte I
J Affect Disord; 2012 Dec; 143(1-3):47-55. PubMed ID: 22858211
[TBL] [Abstract][Full Text] [Related]
13. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
[TBL] [Abstract][Full Text] [Related]
14. Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine.
Sheehan DV; Chokka PR; Granger RE; Walton RJ; Raskin J; Sagman D
Hum Psychopharmacol; 2011 Apr; 26(3):242-51. PubMed ID: 21681815
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the treatment of elderly people with major depressive disorder.
Del Casale A; Girardi P; Brugnoli R; Sani G; Di Pietro S; Brugnoli C; Caccia F; Angeletti G; Serata D; Rapinesi C; Tatarelli R; Kotzalidis GD
Riv Psichiatr; 2012; 47(6):479-88. PubMed ID: 23160108
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
[TBL] [Abstract][Full Text] [Related]
18. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
Lai CH; Hsu YY
Int J Neuropsychopharmacol; 2011 Mar; 14(2):225-35. PubMed ID: 20663271
[TBL] [Abstract][Full Text] [Related]
19. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
20. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
